Web29 May 2024 · The CULPRIT-SHOCK trial is the largest RCT in cardiogenic shock complicating myocardial infarction (62% STEMI) to date comparing IRA-only PCI with immediate PCI of all severe lesions. 2 The CULPRIT-SHOCK trial addressed a contemporary, very high-risk patient population. Roughly half of enrolled patients had been resuscitated …
Assessment and management of shock; a nursing perspective
Web25 Aug 2024 · The major randomized trials for cardiogenic shock showed that death in patients with cardiogenic shock was mainly confined to the first 30 days, with mortality … Web16 Mar 2024 · Patients who had cardiac arrest with ventricular fibrillation (or pulseless ventricular tachycardia) and who had not been resuscitated after receiving three or more … st thomas moore sloane square
One-Year Outcomes after PCI Strategies in Cardiogenic …
Web11 Nov 2024 · In this randomized trial of patients with cardiogenic shock complicating acute myocardial infarction, IABP support did not result in a 6-year survival benefit compared with control, supporting the short-term 30-day and midterm 1-year data. In addition to mortality, there were also no benefits of IABP on other secondary outcome variables. Web12 Oct 2024 · Emergent Revascularization of the culprit coronary artery is the only intervention shown to reduce mortality (Shock trial, 1999). No role for Intraaortic Balloon Pump (IABP SHOCK II trial, 2012). No role for multi-vessel revascularization (CULPRIT-SHOCK trial, 2024). Web30 Oct 2024 · In this multicenter trial, we randomly assigned 706 patients who had multivessel disease, acute myocardial infarction, and cardiogenic shock to one of two … st thomas moore zejtun secondary